Hansa Biopharma AB (publ)

HNSA.ST·Stockholm·Healthcare
Compare
38.22+2.22 (+6.17%)today
At close: Oct 20, 5:29 PM CEST · May be delayed up to 15 min · SEK

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close36.00
Open36.10
Day range35.8638.22
52-week range23.5248.22
Off day high0.00%
Off 52-week high−20.74%
Volume283.70K
Avg. volume (3M)708.74K
Market cap3.81B
EPS (TTM)-7.86
Forward P/E-5.19
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.66
Shares outstanding99.73M
Short interest—
Earnings dateNov 11, 2026
Analyst target73.00
Profit margin0.00%

Against its peers

Compare in full ›
HNSA.ST ARGX ABCL ROIV SRRK IMNM
Market cap 3.81B 54.69B 3.79B 25.22B 5.04B 2.11B
P/E (TTM) — 33.1 — — — —
Forward P/E -5.2 24.4 -15.4 -20.3 -16.4 -7.2
Price/book -7.5 161.5 4.0 6.0 19.8 3.9
Dividend yield — — — — — —
1-year change +4.77% −1.09% +113.80% +94.18% +42.85% +0.18%
Today +6.17% +5.34% −1.84% +0.63% +2.78% +6.86%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All HNSA.ST news ›

From articles in the 4Search news index.

In the news

1mentions in 30 days
1with it in the headline
Negativesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.